Saba Malik

SK pharmteco Names Andrew Fenny Chief Commercial Officer

September 27, 2023 FOR IMMEDIATE RELEASE RANCHO CORDOVA, Ca. (September 27, 2023) – SK pharmteco, a global contract development and manufacturing organization serving the pharmaceutical industry, today announced Andrew (Andy) Fenny as Chief Commercial Officer. In this newly created role, Fenny will shape customer-focused strategies and be responsible for SK pharmteco’s sales and marketing initiatives and […]

SK pharmteco Names Andrew Fenny Chief Commercial Officer Read More »

SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in Center for Breakthrough Medicines

September 19, 2023 FOR IMMEDIATE RELEASE – CBM brings extensive cell and gene therapy expertise to SK pharmteco portfolio and continues SK pharmteco’s strategy to deliver end-to-end, multi-modality support for clients – SK pharmteco previously invested $350 million in CBM in 2022 RANCHO CORDOVA, Ca. & KING OF PRUSSIA, Pa. (Sept. 20, 2023) – SK pharmteco

SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in Center for Breakthrough Medicines Read More »

AMPAC Fine Chemicals Announces Expansion of Capabilities in California

AMPAC Fine Chemicals, an SK Pharmteco company, adds additional pharmaceutical development and engineering capabilities with the opening of a new Complex Molecule Chemistry & Engineering Center Rancho Cordova, California, August 24, 2022 AMPAC Fine Chemicals (AFC), an SK pharmteco Company, a leading manufacturer of Active Pharmaceutical Ingredients in the United States, expanded its pharmaceutical manufacturing capabilities

AMPAC Fine Chemicals Announces Expansion of Capabilities in California Read More »

Joyce Fitzharris

SK pharmteco Announces Appointment of a New President for SK biotek Ireland

Press Release | For Immediate Release  SK pharmteco Inc (SKPT) is pleased to announce that Joyce Fitzharris, currently serving as General Manager, SK biotek Ireland has been promoted to the office of President, SK biotek Ireland. Growth in our business base and projected expansions continue to support SK biotek Ireland’s position as a key contributor

SK pharmteco Announces Appointment of a New President for SK biotek Ireland Read More »

AMPAC Fine Chemicals Creating Jobs with Expansion in Virginia

AMPAC Fine Chemicals Creating Jobs with Expansion in Virginia Investment will triple local employment and strengthen regional pharma industry Furthers SK Group’s plans to invest in and grow U.S. businesses PETERSBURG, Va., May 4, 2021 AMPAC Fine Chemicals (AFC), an SK pharmteco company, is creating more than 150 new jobs and investing more than $25

AMPAC Fine Chemicals Creating Jobs with Expansion in Virginia Read More »

SK pharmteco Expands into Cell and Gene Therapy With the Acquisition of French CDMO Yposkesi

SK pharmteco Expands into Cell and Gene Therapy With the Acquisition of French CDMO Yposkesi Rancho Cordova, California, April 28, 2021 SK pharmteco, a global contract development and manufacturing organization (CDMO) specializing in the manufacture of active pharmaceutical ingredients (APIs) and advanced intermediates, recently announced the acquisition of the major interest in Yposkesi. Yposkesi is

SK pharmteco Expands into Cell and Gene Therapy With the Acquisition of French CDMO Yposkesi Read More »

Scroll to Top

Enter your details to access Marketing Materials